Issue |
Med Sci (Paris)
Volume 32, Number 8-9, Août–Septembre 2016
|
|
---|---|---|
Page(s) | 784 - 786 | |
Section | Forum | |
DOI | https://doi.org/10.1051/medsci/20163208030 | |
Published online | 12 September 2016 |
Cancer :faut-il viser la lune ?
Chroniques génomiques
Does a cancer moonshot make sense?
1
UMR 7268 ADÉS, Aix-Marseille, Université/EFS/CNRS, Espace éthique méditerranéen, hôpital d’adultes la Timone, 264, rue Saint-Pierre, 13385 Marseille Cedex 05, France
2
CoReBio PACA, case 901, parc scientifique de Luminy, 13288 Marseille Cedex 09, France
*
bertrand.jordan@univ-amu.fr
**
brjordan@orange.fr
Abstract
The recently announced “Cancer moonshot” may be greeted with scepticism: the previous “War on cancer” (1971) was not very successful. However the current plan seems well targeted, with emphasis not only on research investment but also on a strong effort to “break down silos” and ensure wide dissemination and use of clinical and molecular data. One big uncertainty, however, is what will happen to the programme after the 2016 presidential election… ‡
© 2016 médecine/sciences – Inserm
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.